Back to Results
First PageMeta Content
Cytokine release syndrome / Health / Hepatitis B / Alemtuzumab / Medicine / Ofatumumab / B-cell chronic lymphocytic leukemia


Arzerra II-27 Final DHPC and communication plan
Add to Reading List

Document Date: 2014-07-31 09:55:30


Open Document

File Size: 165,97 KB

Share Result on Facebook

Company

GSK UK / GlaxoSmithKline / /

IndustryTerm

cancer therapy / Healthcare professionals / medicinal product / administration site / /

MedicalCondition

nasal congestion* Diarrhoea* Bradycardia* Pulmonary / Nausea* Rash* Tachycardia* Hypotension / neutropenia starting / neurologic signs / HBV / herpes virus infection / liver failure / hypersensitivity* Anaphylactic shock* Neutropenia / obstruction Urticaria / urinary tract infection Rare Hepatitis B / nausea / neutropenic sepsis / Hepatitis B / pulmonary oedema / hyperhidrosis / tumour lysis syndrome / fulminant hepatitis / leukaemia / late onset neutropenia / fatigue / prolonged and late-onset neutropenia / Febrile neutropenia / septic shock / Progressive multifocal leukoencephalopathy / chills/rigors / bradycardia / hepatitis / prior HBV infection / pruritus / infections / respiratory tract infection / fungal infections / hypotension / abdominal pain / pneumonia / General disorders / hypertension / bronchospasm / HBV infection / cancer / flushing / fatal infection / hypovolaemia / renal insufficiency / Uncommon Sepsis / chills / cardiac arrhythmias / decreased pulmonary function / neutropenia / Tumour / common Organ Class Infections / pain / pulmonary complications / hepatic failure / urticaria / rigors / cardiac disease / cytokine release syndrome / hepatitis B. Page / thrombocytopenia / leukopenia Agranulocytosis / infection / hepatitis B. In / hypertension* Bronchospasm / cough / rash / /

MedicalTreatment

premedication / vaccination / chemotherapy / intravenous infusion / cancer therapy / antiviral therapy / resuscitation / pharmacotherapy / antibody therapy / /

Organization

Commission on Human Medicines / European Medicines Agency / Medicines and Healthcare Products Regulatory Agency / /

Person

Stephen McDonough / /

/

Position

FFPM Medical Director / physician / General / neurologist / Governor / treating physician / /

Product

acetaminophen / prednisolone / /

Technology

antibodies / chemotherapy / treating cancer / /

URL

www.mhra.gov.uk/yellowcard / /

SocialTag